Synergistic antitumor effects of quercetin and triptolide in hepatocellular carcinoma via modulation of PI3K/AKT/mTOR and Nrf2 signaling pathways
World Journal of Gastroenterology · 07.09.2026 · 32 (33)
DOI: 10.3748/wjg.118638 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Journal of Gastroenterology, online erschienen am 07.09.2026. Verfasst von Irene Maier. Die Arbeit nennt 45 Literaturangaben.
Abstract (Originalsprache)
Phytochemicals derived from traditional Chinese medicine have demonstrated therapeutic potential in liver cancer. Among these, quercetin has been reported to modulate immunosuppressive mechanisms and attenuate liver injury and carcinogenesis. This review focuses on the synergistic effects of triptolide (TP) and quercetin, particularly their co-inhibitory actions on cell proliferation and the mammalian target of rapamycin signaling pathway in preclinical studies. Quercetin administration (80 mg/kg) reduced serum alanine aminotransferase and aspartate aminotransferase levels, as well as biomarkers for oxidative stress. It also mitigated TP-induced inhibition of the protein kinase B/mammalian target of rapamycin pathway and reversed excessive ferroptosis, as evidenced by decreased Fe2+ accumulation and lipid peroxidation (malondialdehyde). In contrast, hepatic glutathione and superoxide dismutase levels were elevated, along with enhanced nuclear expression of nuclear factor erythroid 2-related factor 2. Moreover, mRNA expression of heme oxygenase-1, nicotinamide adenine dinucleotide (phosphate) hydrogen dehydrogenase (quinone) 1, and glutamate-cysteine ligase catalytic subunit was upregulated. Collectively, these findings suggest that quercetin attenuates TP-induced immunological liver injury via activation of the nuclear factor erythroid 2-related factor 2/antioxidant response element signaling pathway. Compared with monotherapy, the combination of TP and quercetin shows enhanced antitumor effects by inhibiting cell proliferation, inducing apoptosis through transcriptional regulation, and suppressing migration and invasion.
Zitieren
APA
Maier, I. (2026). Synergistic antitumor effects of quercetin and triptolide in hepatocellular carcinoma via modulation of PI3K/AKT/mTOR and Nrf2 signaling pathways. World Journal of Gastroenterology, 32(33). https://doi.org/10.3748/wjg.118638
Vancouver
Maier I. Synergistic antitumor effects of quercetin and triptolide in hepatocellular carcinoma via modulation of PI3K/AKT/mTOR and Nrf2 signaling pathways. World Journal of Gastroenterology. 2026;32(33). doi:10.3748/wjg.118638
BibTeX
@article{Maier2026,
author = {Maier, Irene},
title = {Synergistic antitumor effects of quercetin and triptolide in hepatocellular carcinoma via modulation of PI3K/AKT/mTOR and Nrf2 signaling pathways},
journal = {World Journal of Gastroenterology},
year = {2026},
volume = {32},
number = {33},
doi = {10.3748/wjg.118638}
}
EUVIMED